These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6839367)
1. Activity of a kidney epithelial cell growth inhibitor on lung and mammary cells. Holley RW; Armour R; Baldwin JH; Greenfield S Cell Biol Int Rep; 1983 Feb; 7(2):141-7. PubMed ID: 6839367 [TBL] [Abstract][Full Text] [Related]
2. A growth regulatory factor that can both inhibit and stimulate growth. Holley RW; Baldwin JH; Greenfield S; Armour R Ciba Found Symp; 1985; 116():241-52. PubMed ID: 3878272 [TBL] [Abstract][Full Text] [Related]
3. BSC-1 growth inhibitor transforms a mitogenic stimulus into a hypertrophic stimulus for renal proximal tubular cells: relationship to Na+/H+ antiport activity. Fine LG; Holley RW; Nasri H; Badie-Dezfooly B Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6163-6. PubMed ID: 2994063 [TBL] [Abstract][Full Text] [Related]
4. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI). Lehmann W; Widmaier R; Langen P Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells. Dong F; Wu HB; Hong J; Rechler MM J Cell Physiol; 2002 Jan; 190(1):63-73. PubMed ID: 11807812 [TBL] [Abstract][Full Text] [Related]
6. Hyalocytes synthesize and secrete inhibitors of retinal pigment epithelial cell proliferation in vitro. Lazarus HS; Schoenfeld CL; Fekrat S; Cohen S; Carol A; Hageman GS; Hackett S; Chen YS; Vinores SA; Campochiaro PA Arch Ophthalmol; 1996 Jun; 114(6):731-6. PubMed ID: 8639087 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of mink lung epithelial cell proliferation by transforming growth factor-beta is coupled through a pertussis-toxin-sensitive substrate. Howe PH; Cunningham MR; Leof EB Biochem J; 1990 Mar; 266(2):537-43. PubMed ID: 2156499 [TBL] [Abstract][Full Text] [Related]
8. Mammary tumor stimulatory factors as well as mammastatin are produced by the normal human breast epithelial cell line MCF10A. Miller FR; Bukowski J Int J Cancer; 1994 Oct; 59(2):296-7. PubMed ID: 7927932 [No Abstract] [Full Text] [Related]
9. Inhibition of cellular proliferation and modulation of insulin-like growth factor binding proteins by retinoids in a bovine mammary epithelial cell line. Woodward TL; Turner JD; Hung HT; Zhao X J Cell Physiol; 1996 Jun; 167(3):488-99. PubMed ID: 8655603 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of tritiated thymidine incorporation in cultured cells by rat kidney extract. Klein K; Coetzee ML; Madhav R; Ove P J Natl Cancer Inst; 1979 Jun; 62(6):1557-64. PubMed ID: 155753 [TBL] [Abstract][Full Text] [Related]
11. Induction of mammary differentiation by mammary-derived growth inhibitor-related gene that interacts with an omega-3 fatty acid on growth inhibition of breast cancer cells. Wang M; Liu YE; Ni J; Aygun B; Goldberg ID; Shi YE Cancer Res; 2000 Nov; 60(22):6482-7. PubMed ID: 11103817 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane. Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977 [TBL] [Abstract][Full Text] [Related]
13. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line. Johnston PG; Rondinone CM; Voeller D; Allegra CJ Cancer Res; 1992 Dec; 52(24):6860-5. PubMed ID: 1458474 [TBL] [Abstract][Full Text] [Related]
14. Purification of kidney epithelial cell growth inhibitors. Holley RW; Böhlen P; Fava R; Baldwin JH; Kleeman G; Armour R Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5989-92. PubMed ID: 6969400 [TBL] [Abstract][Full Text] [Related]
15. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol. Chen AC; Guo X; Derguini F; Gudas LJ Cancer Res; 1997 Oct; 57(20):4642-51. PubMed ID: 9377581 [TBL] [Abstract][Full Text] [Related]
16. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Bandyopadhyay A; Zhu Y; Cibull ML; Bao L; Chen C; Sun L Cancer Res; 1999 Oct; 59(19):5041-6. PubMed ID: 10519421 [TBL] [Abstract][Full Text] [Related]
17. Purification of a chalone-like inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland. Lehmann W; Samtleben R; Graetz H; Langen P Eur J Cancer Clin Oncol; 1983 Jan; 19(1):101-7. PubMed ID: 6221930 [TBL] [Abstract][Full Text] [Related]
18. Production of growth-inhibitory activity in serum-free medium by human monocytic leukemia cells. Gaffney EV; Tsai SC; Dell'Aquila ML; Lingenfelter SE Cancer Res; 1983 Aug; 43(8):3668-73. PubMed ID: 6344988 [TBL] [Abstract][Full Text] [Related]
19. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Zajchowski DA; Sager R; Webster L Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691 [TBL] [Abstract][Full Text] [Related]
20. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro. Lehmann W; Graetz H; Widmayer R; Langen P Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]